melanoma skin cancer
Conditions
Interventions
Subjects will receive an ultrasound-guided placement of a magnetic marker (the
MaMaLoc marker) in a lesion that will be later removed during surgery. This is
either a locoregional or distal non-palp
Melanoma
Non-palpable
Surgery
Sponsors
Nederlands Kanker Instituut
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. 18 years or older 2. Signed informed consent 3. Scheduled for either * Surgery of clinically occult (sub)cutaneous or muscular melanoma lesion(s) (group 1) OR * Complete Lymph Node Dissection of inguinal or axillary region (group 2)
Exclusion criteria
Exclusion criteria: - MRI necessary in period between placement of magnetic marker and surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Retrieval rate: in how many cases is the surgeon able to adequately localise and remove the marked lesion using the magnetic detection technology. | — |
Secondary
| Measure | Time frame |
|---|---|
| 2. Radiologist satisfaction: to what extent is placing the experimental magnetic marker comparable to the current clinical practice, what is different and what are (dis)advantages? 3. Surgeon satisfaction: how does intraoperative localisation using the magnetic technology compare to the current clinical practice, what is different and what are (dis)advantages? | — |
Countries
The Netherlands
Outcome results
None listed